Laura Williams

Direttore Tecnico/Scientifico/R&S presso ARDELYX, INC.

Patrimonio netto: 2 M $ in data 30/04/2024

61 anni

Health Technology

Consumer Services

Posizioni attive di Laura Williams

Società	Posizione	Inizio	Fine
ARDELYX, INC.	Direttore Tecnico/Scientifico/R&S	01/01/2021	-
ARDELYX, INC.	Corporate Officer/Principal	01/11/2020	-

Società	Posizione	Inizio	Fine
AMAG PHARMACEUTICALS, INC.	Corporate Officer/Principal	07/09/2017	01/01/2020
Myovant Sciences, Inc. Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY.	Direttore Tecnico/Scientifico/R&S	01/09/2016	01/08/2017
IMARA	Direttore/Membro del Consiglio	30/06/2021	-
IMARA	Independent Dir/Board Member	30/06/2021	-

University of Iowa	Doctorate Degree
Mississippi State University	Undergraduate Degree
University of Washington	Graduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1

Settori

Health Technology	5
Consumer Services	4

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
ARDELYX, INC.	Health Technology

Aziende private	3
AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.	Health Technology
Imara, Inc. Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA.	Health Technology
Myovant Sciences, Inc. Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY.	Health Technology